GIUDICI, MARCO
GIUDICI, MARCO
Dipartimento di Scienze Farmacologiche e Biomolecolari
Fenofibrate attenuates cardiac and renal alterations in young salt-loaded spontaneously hypertensive stroke-prone rats through mitochondrial protection
2018 L. Castiglioni, A. Pignieri, F. Melania, M. Giudici, M. Crestani, N. Mitro, A. Mauro, Z. Carlamaria, R. Daniela, F. Claudia, F. Fabio, U. Guerrini, E. Tremoli, L. Sironi, P. Gelosa
Attenuation of diet-induced obesity and induction of white fat browning with a chemical inhibitor of histone deacetylases
2017 A. Ferrari, E. Fiorino, R. Longo, S. Barilla, N. Mitro, G. Cermenati, M. Giudici, D. Caruso, A. Mai, U. Guerrini, E.S.R. DE FABIANI, M. Crestani
LT175 is a novel PPARα/γ ligand with potent insulin sensitizing effects and reduced adipogenic properties
2014 F. Gilardi, M. Giudici, N. Mitro, O. Maschi, U. Guerrini, G. Rando, A. Maggi, G. Cermenati, A. Laghezza, F. Loiodice, G. Pochetti, A. Lavecchia, D. Caruso, E. De Fabiani, K. Bamberg, M. Crestani
The sirtuin class of histone deacetylases: Regulation and roles in lipid metabolism
2014 E. Fiorino, M. Giudici, A. Ferrari, N. Mitro, D. Caruso, E. De Fabiani, M. Crestani
Site-Directed Mutagenesis to Study the Role of Specific Amino Acids in the Ligand Binding Domain of PPARs
2013 N. Mitro, F. Gilardi, M. Giudici, C. Godio, E. Scotti, M. Crestani
Molecular determinants for nuclear receptors selectivity: chemometric analysis, dockings and site-directed mutagenesis of dual peroxisome proliferator-activated receptors α/γ agonists
2013 A. Carrieri, M. Giudici, M. Parente, M. De Rosas, L. Piemontese, G. Fracchiolla, A. Laghezza, P. Tortorella, G. Carbonara, A. Lavecchia, F. Gilardi, M. Crestani, F. Loiodice
Inflammatory serum proteome pattern in mice fed a high-fat diet
2013 E. Gianazza, C. Sensi, I. Eberini, F. Gilardi, M. Giudici, M. Crestani
STUDY OF THE MOLECULAR MECHANISM UNDERLYING PPAR ACTIVATION BY LT175, A NOVEL DUAL PPARA/G LIGAND THAT AMELIORATES THE METABOLIC PROFILE AND INSULIN SENSITIVITY IN A MOUSE MODEL OF INSULIN RESISTANCE
2012 M. Giudici
Linking epigenetics to lipid metabolism: Focus on histone deacetylases
2012 A. Ferrari, E. Fiorino, M. Giudici, F. Gilardi, A. Galmozzi, N. Mitro, G. Cermenati, C. Godio, D. Caruso, E. De Fabiani, M. Crestani
Synthesis, characterization and biological evaluation of ureidofibrate-like derivatives endowed with peroxisome proliferator-activated receptor activity
2012 L. Porcelli, F. Gilardi, A. Laghezza, L. Piemontese, N. Mitro, A. Azzariti, F. Altieri, L. Cervoni, G. Fracchiolla, M. Giudici, U. Guerrini, A. Lavecchia, R. Montanari, C. Di Giovanni, A. Paradiso, G: Pochetti, G.M. Simone, P. Tortorella, M. Crestani, F. Loiodice
Generation of a liver-specific HDAC7 KO mouse model and effect of selective HDAC inhibitors on cholesterol 7α-hydroxylase gene in mice
2011 C. Multineddu, F. Gilardi, E. Fiorino, M. Giudici, A. Galmozzi, N. Mitro, E.S. R De Fabiani, D. Caruso, M. Crestani
Study of the mechanism of action of LT175, a dual PPAR ligand that ameliorates the metabolic profile and insulin sensitivity in a mouse model of insulin resistance
2011 M. Giudici, F. Gilardi, N. Mitro, F. Loiodice, G. Fracchiolla, A. Laghezza, G. Pochetti, G. Cermenati, A. Lavecchia, M. Crestani
Study of the mechanism of action of LT175, a dual PPAR ligand that ameliorates the metabolic profile and insulin sensitivity in different mouse models
2011 M. Giudici, F. Gilardi, N. Mitro, F. Loiodice, G. Fracchiolla, A. Laghezza, G. Pochetti, R. Montanari, A. Lavecchia, A.C. Maggi, E.S.R. De Fabiani, D. Caruso, M. Crestani
Involvement of histone deacetylases (HDAC) in the molecular regulatory pathway of cholesterol 7α-hydroxylase: an in vitro approach with selective HDAC inhibitors
2011 E. Fiorino, F. Gilardi, C. Multineddu, N. Mitro, M. Giudici, C. Godio, A. Galmozzi, E. De Fabiani, D. Caruso, M. Crestani
Characterization of a cellular model for studing the effect of HDACs silencing on cholesterol homeostasis
2010 C. Multineddu, E. Fiorino, F. Gilardi, A. Galmozzi, M. Giudici, N. Mitro, E.S.R. De Fabiani, D. Caruso, M. Crestani
Changing the binding mode to peroxisome proliferator activated receptor (PPAR) alpha/gamma: a new ligand with improved antidiabetic and antiobesity properties
2010 N. Mitro, F. Gilardi, M. Giudici, F. Loiodice, G. Fracchiolla, A. Laghezza, G. Pochetti, A. Lavecchia, U. Guerrini, E. Tremoli, G. Rando, A.C. Maggi, E. Novellino, M. Crestani
LT175, a dual PPAR ligand, increases energy metabolism and improves the diabetic phenotype in different mouse models
2010 M. Giudici, F. Gilardi, N. Mitro, F. Loiodice, G. Pochetti, A. Lavecchia, A. Maggi, E. De Fabiani, D. Caruso, M. Crestani
Improved lipid metabolism and reduced fat deposition in a mouse model of diet-induced obesity (DIO) with a new dual PPAR alpha/gamma ligand
2009 F. Gilardi, N. Mitro, M. Giudici, G. Cermenati, U. Guerrini, E. Tremoli, G. Rando, A. Maggi, F. Loiodice, G. Fracchiolla, A. Laghezza, G. Pochetti, A. Lavecchia, E. De Fabiani, D. Caruso, M. Crestani